(Date:1/8/2009)...Newswire-FirstCall/ -- WellPoint, Inc. (NYSE: WL...rship Awards for its, and its,affiliated health p...s at,WellPoint site was honored with a Silver Awa...lPoint Foundation,s Web site received a Gold Award... a Platinum Award for Best Healthcare,Content for...
(Date:1/8/2009)... /PRNewswire/ -- Prism Pharmaceuticals announced...e payment from Paul Capital Healthcare (formerly P...form of Paul Capital. The milestone payment is tr...ation (FDA) approval of Prism,s new drug applicati...on, a novel, patent-protected, cosolvent free form...
(Date:1/8/2009)...ando Will Feature Strategies and Tools That Incr...ofitability , , WOBURN, Mass., Jan. 8 /PRNewsw...ion - ranging from the employment-related decline ... health insurance selection - the retention of ind...rity for the nation,s health insurance companies. ...
(Date:1/8/2009).... 8 Poniard,Pharmaceuti...company focused on,innovative oncology therapies,...goals for development of picoplatin, its lead prod...tinum-based chemotherapy agent with the potential ...indications, combinations and,formulations. It is...
Breaking Medicine News(10 mins):Health News:WellPoint Receives Seven eHealthcare Leadership Awards 2Health News:WellPoint Receives Seven eHealthcare Leadership Awards 3Health News:Prism Pharmaceuticals to Receive $10 Million Milestone Payment from Paul Capital Healthcare 2Health News:Prism Pharmaceuticals to Receive $10 Million Milestone Payment from Paul Capital Healthcare 3Health News:World Health Care Congress and ConnextionsHealth Will Host Leadership Summit to Address Member Retention for Health Insurance Plans 2Health News:World Health Care Congress and ConnextionsHealth Will Host Leadership Summit to Address Member Retention for Health Insurance Plans 3Health News:Poniard Pharmaceuticals Provides 2009 Clinical Data Goals for Picoplatin 2Health News:Poniard Pharmaceuticals Provides 2009 Clinical Data Goals for Picoplatin 3Health News:Poniard Pharmaceuticals Provides 2009 Clinical Data Goals for Picoplatin 4Health News:Poniard Pharmaceuticals Provides 2009 Clinical Data Goals for Picoplatin 5...ment has decided to spend US$2 million to curb a m...yers and nurses from the country.// This amount w...ls retention package. The state-controlled Herald ...on of a special government taskforce on skills ret...
...s, rather than their less-developed neighbors, are...cancer//that strikes children and teens, researche...s Medical Center Dallas have found. The research, ...vides a clue to how the cancer arises, but also me...
...ts are unprepared for skilled prescribing, warn do...ing in the UK is abundant, write Jeffrey Aronson a...derprescribed and prescription errors are common, ... in hospitals. The reasons for these errors are ...
...nd that it is better to alter the dosage of senior... of the pancreas //and biliary region, by bringing...examination as well as the risk of complications. ...chnical Radiology at Nagoya University School of H...
Other Medicine News:Health News:Incentives to stop Zimbabwe skills exodus 2Health News:Mature Muscle Fibers Can Revert to Become Cancerous 2Health News:Many Medical Students Unprepared for Skilled Prescribing 2(Date:12/17/2008)...tists show for the first time that normal stem cel... tissues , , MEMPHIS, Tenn., Dec. 17 /PRNew...dren,s Research Hospital have answered a central q...ls can give rise to tumors. Stem cells are immatur... mature differentiated cells that compose the rang...
(Date:12/17/2008)...if., Dec. 17 PEAK Surgical, Inc., ... tissue dissection system based on a,proprietary ... Drug,Administration (FDA) has granted the compan...System for cutting and coagulation of soft tissue ... and throat), gynecologic,orthopedic, arthroscop...
(Date:12/17/2008)... 17 Delcath Systems, In...nt of Pamela R. Contag, Ph.D., to Delcath,s Board ...ecutive with extensive experience working with int...OGO: http://www.newscom.com/cgi-bin/prnh/2008111...alt Technologies, Inc. in 2006 and served as CEO. ...
(Date:12/17/2008)...lif., Dec. 17 Neurobiolo... ) today announced that an independent,Data Safet...current clinical,trials of Viprinex(TM) for the t... show benefit. As a result, the company has termin...btain and analyze the data before evaluating the,...
Breaking Medicine Technology:Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 2Molecular Marker Identifies Normal Stem Cells as Intestinal Tumor Source 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4Delcath Adds Dr. Pamela R. Contag to Its Board of Directors 2Delcath Adds Dr. Pamela R. Contag to Its Board of Directors 3Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis 2Codexis Inc Files Registration Statement for Proposed Initial Public Offering 4576 1Codexis Inc Files Registration Statement for Proposed Initial Public Offering 4576 2Launching a global alliance for pharmacogenomics 2880 1Launching a global alliance for pharmacogenomics 2880 2CCA Industries Inc Announces First Quarter Results 16721 1CCA Industries Inc Announces First Quarter Results 16721 2MAQUET Cardiovascular Launches HEARTSTRING III Proximal Seal System for Coronary Artery Bypass Graft Surgery 16716 1MAQUET Cardiovascular Launches HEARTSTRING III Proximal Seal System for Coronary Artery Bypass Graft Surgery 16716 2MAQUET Cardiovascular Launches HEARTSTRING III Proximal Seal System for Coronary Artery Bypass Graft Surgery 16716 3...ERT Trial Presented at EULAR, BARCELONA, Spain, Ju...ed today at the European League Against Rheumatism...showed that patients with,ankylosing spondylitis (... years experienced significant improvement in spin...s showed sustained,reductions in spinal inflammati...
...patient trial show those treated with,Prexige expe...sure,compared to ibuprofen[1] , * Many patients wi...ven small changes in blood pressure can impact,car...re than 50 countries and currently under,review in...itzerland, June 15, 2007 - Patients with osteoarth...
Other Medicine Technology:Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 2Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 3Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 4Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 5Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 6Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 7Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 8Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 9Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 10Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 11Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 12Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 2Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 3Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 4Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 5Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 6Inquire
Protects the skin over extended wearing time from irritating discharge. Flextend skin barrier is the barrier of choice for urostomies and ileostomies. Security and confidence assured with internal no
Inquire
Inquire
Medicine Products: